Shares of major tobacco companies moved higher Monday following new guidance from the U.S. Food and Drug Administration on enforcement priorities for certain new tobacco products.
British American Tobacco (NYSE:BTI) led the move, with shares up 4.87% on the session. Philip Morris International (NYSE:PM) shares rose 4.26%, and Altria Group (NYSE:MO) advanced 2.57%.
The FDA published updated enforcement priorities for e-vapor products and oral nicotine pouches that are being marketed without premarket authorization but that have premarket tobacco applications or supplemental applications currently under review. The guidance explains the agency's intent to allocate enforcement resources differently for products in that category.
Specifically, the agency said it does not intend to prioritize enforcement against nicotine pouch and e-vapor products that have a pending premarket tobacco application or a supplemental application that has been accepted and pending for more than 180 days. The FDA characterized the approach as a way to better allocate its resources, while also emphasizing that products lacking authorization remain illegal under existing law.
The guidance also states the FDA will publish and maintain a publicly available list of products that it does not intend to prioritize enforcement against. The agency made clear that inclusion on that list - or otherwise falling within the new enforcement priorities - does not affect whether a product will ultimately receive authorization through the premarket tobacco application process.
On product characteristics, the FDA said it would consider whether a product has high nicotine content when evaluating enforcement priority, but the agency did not define what level of nicotine would qualify as "high."
Market analysts reacted positively to the guidance. Morgan Stanley analysts said: "We view the FDA’s new guidance on nicotine pouch/e-vapor as positive for PM (and to a lesser extent MO) by providing a pathway for accelerated new product launches." Jefferies analysts added: "This could enable new eVapour and Pouch products from Big Tobacco and responsible independents to be commercialised on the US market. We see this as a +ve for BAT, PM and Japan Tobacco and a gentle +ve for MO."
The guidance alters the immediate regulatory landscape for companies with pending applications, but it leaves open key questions about long-term authorization and specific product thresholds. Investors responded to the near-term regulatory clarity with a repricing of equity in the sector on Monday.